Drug Shortage Report for PRISTIQ
| Report ID | 177973 |
| Drug Identification Number | 02321092 |
| Brand name | PRISTIQ |
| Common or Proper name | PRISTIQ |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DESVENLAFAXINE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30's |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-03-17 |
| Actual start date | 2023-03-16 |
| Estimated end date | 2023-03-31 |
| Actual end date | 2023-03-20 |
| Shortage status | Resolved |
| Updated date | 2023-03-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2023-03-21 | French | Compare |
| v8 | 2023-03-21 | English | Compare |
| v7 | 2023-03-17 | English | Compare |
| v6 | 2023-03-16 | French | Compare |
| v5 | 2023-03-16 | English | Compare |
| v4 | 2023-02-13 | French | Compare |
| v3 | 2023-02-13 | English | Compare |
| v2 | 2022-12-12 | French | Compare |
| v1 | 2022-12-12 | English | Compare |
Showing 1 to 9 of 9